GSK shares dive as weaker sales and mounting costs unnerve investors
The Guardian

British pharma company reports declining profits amid weaker vaccine sales and looming patent loss for blockbuster HIV drug Business live – latest updates Shares in GSK slid on Wednesday despite the UK drugmaker reporting better than expected financial…
Summary from The Guardian
Read the full story on The GuardianFollow












